Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 257-268

Bentham Science Publishers

Access to resources Recommend Favorite

Exploring QSARs of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Tyrosine Kinase Inhibitors by MLR, PLS and PC-ANN

By  

Current Pharmaceutical Design, Vol. 19, Iss. 12, 2013-01 ,pp. : 2237-2244

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitory effects of SY0916, a platelet-activating factor receptor antagonist, on the angiogenesis of human umbilical vascular endothelial cells

By Wu Lian-Qiu   OuYang Xue-Yu   Liu Yang   Peng Shan-Ying   Wang Lin   Wang Wen-Jie  

Journal of Asian Natural Products Research, Vol. 13, Iss. 11, 2011-10 ,pp. : 984-992

Taylor & Francis Ltd

Access to resources Recommend Favorite

Dissociation between the Ca 2+ signal and tube formation induced by vascular endothelial growth factor in bovine aortic endothelial cells

By Kawasaki J.   Hirano K.   Hirano M.   Nishimura J.   Nakatsuka A.   Fujishima M.   Kanaide H.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 19-29

Elsevier

Access to resources Recommend Favorite

Co-Expression of Vascular Endothelial Growth Factor and Interleukin-1 Receptor Antagonist Improves Human Islet Survival and Function

By Narang Ajit   Sabek Omaima   Gaber Ahmed   Mahato Ram  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 1970-1982

Springer Publishing Company

Access to resources Recommend Favorite